The genus Crataegus: Chemical and pharmacological perspectives

Revista Brasileira de Farmacognosia

Volumn 22, Issue 5, 2012, Pages 1187-1200

  Kumar, Dinesh ^a   Arya, Vikrant ^b   Bhat, Zulfiqar Ali ^a   Khan, Nisar Ahmad ^a   Prasad, Deo Nandan ^c  

^a UNIVERSITY OF KASHMIR   (India)

^b Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy   (India)

^c Shivalik College of Pharmacy   (India)

Author keywords

Crataegus; Flavonoids; Hawthorn; Maloideae Rosaceae; Thorny bush

Indexed keywords

ACETYLCHOLINE; ADENOSINE; ANTHOCYANIN; APIGENIN; ASCORBIC ACID; CATECHIN; CATECHOLAMINE; CHLOROGENIC ACID; CHOLINE; CRATAEGUS EXTRACT; EPICATECHIN; EUDESMANOLIDE DERIVATIVE; FLAVONOID; GALLIC ACID; HESPERETIN; HYPERIN; NARINGENIN; OLEANOLIC ACID; PHENETHYLAMINE; PHENOL DERIVATIVE; POLYSACCHARIDE; PROANTHOCYANIDIN; PROCYANIDIN; SAPONIN; TANNIN; TRITERPENE; TYRAMINE; UNINDEXED DRUG; URSOLIC ACID; VITEXIN;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ANXIETY; CARDIOVASCULAR DISEASE; CATARACT; CENTRAL NERVOUS SYSTEM DISEASE; CONGESTIVE HEART FAILURE; CRATAEGUS; CYTOTOXICITY; DEPRESSION; EYE DISEASE; HEART INFARCTION; HUMAN; HYPOGLYCEMIA; IMMUNOPATHOLOGY; NONHUMAN; RADIATION PROTECTION; REVIEW; ROSACEAE; TRADITIONAL MEDICINE;

EID: 84866917059     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2012005000094     Document Type: Review

References (90)

1. Ahmed AA, Khattab AM, Grace MH, Sahl MM 2001. A new eudesmanolide from Crataegus flava fruits. Fitoterapia 72: 756-759.
2. Amanzadeh Y, Khanavi M, Khatamsaz M, Rajabi A, Ebrahimi SES 2007. High performance thin-layer chromatographic fingerprints of flavonoids and phenol carboxylic acids for standardization of Iranian species of the genus Crataegus L. Iranian J Pharm Sci 3: 143-152.
3. Ammon HPT, Handel M 1981a. Crataegus, toxicology and pharmacology, Part 1: toxicity Planta Med 43: 105-120.
4. Ammon HPT, Handel M 1981b. Crataegus, toxicology and pharmacology, Part III: Planta Med 43: 313-322.
5. Andrade-Cetto A, Heinrich M 2005. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. J Ethnopharmacol 99: 325-348.
6. Aneta W, Oszmianski J 2007. Influence of polyphenols isolated from Scutellaria baicalensis Georgi and Crataegus oxyacantha on the oxidative stability of cholesterol in butter stored in various conditions. Eur Food Res Technol 224: 635-642.
7. Anna S, Oszmian J, Aneta W 2007. Antioxidant activity of phenolic compounds of Hawthorn, pine, skullcap. Food Chemistry 103: 853-859.
8. Arrieta J, Siles-Barrios D, García-Sanchez J, Reyes-Trejo B, Sanchez-Mendoza M 2010. Relaxant effect of the extracts of Crataegus mexicana on guinea pig tracheal smooth muscle. Pharmacogn J 2: 40-46.
9. Arslan R, Bor Z, Bektas N, Mericli A H, Ozturk Y 2011. Antithrombotic effects of ethanol extract of Crataegus orientalis in the carrageenan-induced mice tail thrombosis model. Thromb Res 127: 210-213.
10. Bahorun T, Aumjaud E, Ramphul H, Rycha M, Luximon-Ramma A, Trotin F, Aruoma OI 2003. Phenolic constituents and antioxidant capacities of Crataegus monogyna (Hawthorn) callus extracts. Nahrung 47: 191-198.
11. Bahri-Sahloul R, Ammar S, Fredj RB, Saguem S, Gree S, Trotin F, Skhiri FH 2009. Polyphenol contents and antioxidant activities of extracts from flowers of two Crataegus azarolus L. varieties. Pakistan J Biol Sci 12: 660-668.
12. Batyuk VS 1966. Structure of the flavonoids of Crataegus curvisepala. Chem Nat Compd 2: 233-234.
13. Belz GG, Butzer R, Gaus W, Loew D 2002. Camphor-Crataegus berry extract combination dose-dependently reduces tilt induced fall in blood pressure in orthostatic hypotension. Phytomedicine 9: 581-588.
14. Benli M, Yig N, Geven F, Kerim G, Bingo U 2008. Antimicrobial activity of endemic Crataegus tanacetifolia (Lam.) Pers and observation of the inhibition effect on bacterial cells. Cell Biochem Funct 26: 844-851.
15. Bersin T, Muller A, Schwarz H 1955. Ingredients of Crataegus oxyacantha L. III. Heptahydroxyflavan glycoside. Arzneimittelforschung 5: 490-491.
16. Blesken R 1992. Crataegus in cardiology. Fortschr Med 15: 290-292.
17. Blumenthal M, Busse W, Goldberg A 1988. The complete Germen commission E Monographs, Boston MA: American Botanical Council, p. 142-144.
18. Bykov VI, Glyzin VI 1972. Flavonoids of the genus Crataegus. Chem Nat Compd 8: 672-673.
19. Chang Q, Zuo Z, Harrison F, Chow MS 2002. Hawthorn. J Clin Pharmacol 42: 605-612.
20. Chen JD, Wu YZ, Tao ZL, Chen ZM, Liu XP 1995. Hawthorn (shan zha) drink and its lowering effect on blood lipid levels in humans and rats. World Rev Nutr Diet 77: 147-54.
21. Chen J, Song S, He J, Xu S 2008. A study of the chemical constituents of the leaves of Crataegus pinnatifida. Asian J Trad Med 3: 80-83.
22. ®) in the treatment of patients with congestive heart failure NYHA II. Phytomedicine 10: 363-369.
23. Demiray S, Pintado ME, Castro PML 2009. Evaluation of phenolic profiles and antioxidant activities of Turkish medicinal plants: Tilia argentea, Crataegi folium leaves and Polygonum bistorta roots. World Acad Sci Eng Technol 54: 312-317.
24. Donmez AA 2004. The genus Crataegus L. (Rosaceae) with special reference to hybridisation and biodiversity in Turkey. Turk J Bot 28: 29-37.
25. Ebrahimzadeh MA, Bahramian F 2009. Antioxidant activity of Crataegus pentaegyna fruit extract used as traditional medicine in Iran. Pakistan J Biol Sci 12: 413-419.
26. Furst R, Zirrgiebel U, Totzke F, Zahler S, Vollmar AM, Koch E 2010. The Crataegus extract WS 1442 inhibits balloon catheter-induced intimal hyperplasia in the rat carotid artery by directly influencing PDGFR-beta. Atherosclerosis 2: 409-417.
27. Garjani A, Nazemiyeh H, Maleki N, Valizadeh H 2000. Effects of extracts from flowering tops of Crataegus meyeri A. Pojark. on ischaemic arrhythmias in anaesthetized rats. Phytother Res 14: 428-431.
28. Gazizov FY, Glushenkova AI 1996. Phospholipids of the pericarp of Crataegus turkestanica. Chem Nat Compd 31: 465-466.
29. Guven K, Yucel E, Cetintas F 2006. Antimicrobial activities of fruits of Crataegus and Pyrus. Species. Pharm Biol 44: 79-83.
30. Hanus M, Lafon J, Mathieu M 2004. Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Curr Med Res Opin 20: 63-71.
31. Horvat RJ, Chapman GW 2007. Identification of volatile compounds from ripe Mayhaw fruit (Crataegus opaca, C. aestzvalzs, and C. rufula. J Food Quality 14: 307-312.
32. Hosseinimehr SJ, Azadbakht M, Mousavi SM, Mahmoudzadeh A, Akhlaghpoor S 2007. Radioprotective effects of hawthorn fruit extract against gamma irriradiation in mouse bone marrow cells. J Radiat Res 48: 63-67.
33. Houser D 2006. Supplement spotlight: Hawthorn. Hu L, Xiong CL 2006. The influence of medicated serum with root of Crataegus cuneata on human sperm motility parameters in vitro. China J Chinese Materia Med 4: 333-335.
34. Huang Y, Chen ZY, Ho WKK 2004. Crataegus (Howthorn). In: Lester P, Choon NO, Barry H, Herbal and traditional medicine, biomolecular and clinical aspects. China 21 CRC Press DOI: 10.1201/9780203025901.ch21.
35. Ikeda T, Ogawa Y, Nohara T 1999. A new triterpenoid from Crataegus cuneata, Chem Pharm Bull 47: 1487-1488.
36. Iwamoto M, Sato T, Ishizaki T 1981. The clinical effect of Crataegutt in heart disease of ischemic or hypertensive origin. A multicenter double-blind study. Planta Med 42: 1-16.
37. Jayalakshmi R, Thirupurasundari CJ, Niranjali DS 2006. Pretreatment with alcoholic extract of Crataegus oxycantha (AEC) activates mitochondrial protection during isoproterenol-induced myocardial infarction in rats. Mol Cell Biochem 292: 59-67.
38. Ju LY 2005. Crataegus oxyacantha (aubepine) in the use as herb medicine in France. Zhongguo Zhong Yao Za Zhi 30: 634-40.
39. Kao ES, Wang CJ, Lin WL, Chu CY, Tseng TH 2007. Effects of polyphenols derived from fruit of Crataegus pinnatifida on cell transformation, dermal edema and skin tumor formation by phorbol ester application. Food Chem Toxicol 45: 1795-1804.
40. Kao ES, Wang CJ, Lin WG, Yin YF, Wang CP, Tseng TH 2005. Anti-inflammatory potential of flavonoid contents from dried fruit of Crataegus pinnatifida in vitro and in vivo. J Agric Food Chem 53: 430-436.
41. Kashnikova MV 1984. Flavonoids of the flowers of Crataegus sanguinea. Chem Nat Compd 20: 105-106.
42. Kashnikova M V, Sheichenko V I, Gluzin VI, Samylina I A 1984. Acetylvitexin-a new flavonoid from the flowers of Crataegus sanguinea. Chem Nat Compd 20: 106.
43. Khalil R, Abuharfeil N, Shabsoug B 2008. The effect of Crataegus aronica aqueous extract in rabbits fed with high cholesterol diet. Eur J Sci Res 22: 352-360.
44. Kirakosyan A, Seymour E, Kaufman BP, Warber S, Bolling S, Chang CS 2003. Antioxidant capacity of polyphenolic extracts from leaves of Crataegus laevigata and Crataegus monogyna (Hawthorn) subjected to drought and cold stress. J Agr Food Chem 51: 3973-3976.
45. Kocyildiz ZC, Birman H, Olgac V, Akgun-Dar K, Meliko G, Mericli AH 2006. Crataegus tanacetifolia leaf extract prevents L-NAME-induced hypertension in rats: a morphological study. Phytother Res 20: 6-70.
46. Kovaleva AM, Goncharov NF, Komissarenko AN 2009. GC/ MS study of essential oil components from flowers of Crataegus jackii, C. robesoniana, and C. flabellate. Chem Nat Compd 45: 582-584.
47. Kuliev VB, Poletaeva LV 1983. Polysaccharides of Crataegus. II. Polysaccharides of the fruit of Crataegus meyeri. Chem Nat Compd 18: 612-613.
48. Kuliev VB, Poletaeva, LV 1984. Polysaccharides of Crataegus II. Polysaccharides of the fruit of Crataegus meyeri. Chem Nat Compd 20: 100-101.
49. Li F, Yuan Q, Rashid F 2009. Isolation, purification and immunobiological activity of a new water-soluble bee pollen polysaccharide from Crataegus pinnatifida Bge. Carbohyd Polym 78: 80-88.
50. Lin Y, Vermeer MA Trautwein EA 2009. Triterpenic acids present in hawthorn lower plasma cholesterol by inhibiting intestinal ACAT activity in hamsters. eCAM 1-9: doi:10.1093/ecam/nep007.
51. Liu P, Kallio H, Lu D, Zhou C, Ou S, Yang B 2010. Acids, sugars, and sugar alcohols in chinese hawthorn (Crataegus spp.) fruits. J Agric Food Chem 58: 1012-1019.
52. Ljubuncic P, Azaizeh H, Cogan U, Bomzon A 2006. The effects of a decoction prepared from the leaves and unripe fruits of Crataegus aronia in streptozotocininduced diabetic rats. J Complement Med 3: 6. doi: 10.2202/1553-3840.1027.
53. Ljubuncic P, Portnaya I, Cogan U, Azaizeh H, Bomzon A 2005. Antioxidant activity of Crataegus aronia aqueous extract used in traditional Arab medicine in Israel. J Ethnopharmacol 101: 153-161.
54. Long SR, Carey RA, Crofoot KM, Proteau PJ, Filtz T M 2006. Effect of hawthorn (Crataegus oxycantha) crude extract and chromatographic fractions on multiple activities in a cultured cardiomyocyte assay. Phytomedicine 13: 643-650.
55. Maharik N, Elgengaihi S, Taha H 2009. Anthocyanin production in callus cultures of Crataegus sinaica boiss. Int J Acad Res 1: 30-34.
56. Maurya R, Yadav PP 2005. Furanoflavonoids: An overview. Nat Prod Rep 22: 400-424.
57. Melikoglu G, Bitis L, Mericli AH 2004. Flavonoids of Crataegus microphylla. Nat Prod Res 18: 211-213.
58. Miller AL 1998. Botanical influences on cardiovascular disease. Altern Med Rev 3: 422-431.
59. Min BS, Kim YH, Lee SM, Jung HJ, Lee JS, Na MK, Lee CO, Lee JP, Bae K 2000. Cytotoxic triterpenes from Crataegus pinnatifida. Arch Pharm Res 23: 155-158.
60. Monographs 2010. Crataegus oxyacantha Hawthorn Monograph. Altern Med Rev 15: 164-167.
61. Nikolov NT, Vodenicharov RI 2003. Di-C-glycosides from Crataegus monogyna. Chem Nat Compd 11: 436-437.
62. Orhan I, Ozcelik B, Kartal M, Ozdeveci B, Duman H 2007. HPLC Quantification of vitexine-2-O-rhamnoside and hyperoside in three Crataegus species and their antimicrobial and antiviral activities. Chromatographia 66: S153-S157.
63. Petkov V 1979. Plants and hypotensive, antiatheromatous and coronarodilatating action. Am J Chinese Med 3: 197-236.
64. Rayyan S, Fossen T, Nateland HS, Andersen OM 2005. Isolation and identification of flavonoids, including flavone rotamers, from the herbal drug 'Crataegi folium cum flore' (hawthorn). Phytochem Anal 16: 334-41.
65. Rewerski W, Lewak S 1967. Some pharmacological properties of flavan polymers isolated from hawthorn (Crataegus oxyacantha). Arzneimittelforschung 17: 490-491.
66. Rigelsky JM, Sweet BV 2002. Hawthorn: Pharmacology and therapeutic uses. Am J Health Syst Pharm 59: 417-422.
67. Ringl A, Prinz S, Huefner A, Kurzmann M, Kopp B 2007. Chemosystematic value of flavonoids from Crataegus x macrocarpa (Rosaceae) with special emphasis on (R)-and (S)-eriodictyol-7-O-glucuronide and luteolin-7-Oglucuronide. Chem Biodivers 4: 154-162.
68. Robertson KR 1974. The genera of Rosaceae in the southeastern United States. J Arnold Arboretum 55: 303B-332, 334B-401, 611B-662.
69. Schroder D, Weiser M, Klein P 2003. Efficacy of a homeopathic Crataegus preparation compared with usual therapy for mild (NYHA II) cardiac insufficiency: results of an observational cohort study. Eur J Heart Fail 5: 319-26.
70. Shahat AA, Hammouda F, Ismail SI, Azzam SA, De Bruyne T, Lasure A, Van Poel B, Pieters L, Vlietinck AJ 1996. Anti-complementary activity of Crataegus sinaica. Planta Med 62: 10-13.
71. Shahat A, Ismail S, Hammouda F 1998. Anti-HIV activity of flavonoids and proanthocyanidins from Crataegus sinaica. Phytomedicine 2: 133-136.
72. Sozer U, Donmez AA, Mericli AH 2006. Constituents from the leaves of Crataegus davisii Browicz. Sci Pharm 74: 203-208.
73. Svedstrom U, Vuorela H, Kostiainen R, Tuominen J, Kokkonen J, Rauha JP, Laakso I, Hiltunen R 2002. Isolation and identification of oligomeric procyanidins from Crataegus leaves and flowers. Phytochemistry 60: 821-825.
74. Tabach R, Mattei R, Carlini EL 2009. Pharmacological evaluation of a phytotherapeutic product-CPV (dry extract of Crataegus oxyacantha L., Passiflora incarnata L. and Valeriana officinalis L.) in laboratory animals. Rev Bras Farmacogn 19: 255-260.
75. Tadic VM, Dobric S, Markovic GM, Sofija M, Tanja S 2008. Anti-inflammatory, gastroprotective, free-radicalscavenging and antimicrobial activities of hawthorn berries ethanol extract. J Agr Food Chem 56: 7700-7709.
76. Tankanow R, Tamer HR, Streetman DS, Smith SG, Welton JL, Annesley T, Aaronson KD, Bleske BE 2003. Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J Clin Pharmacol 43: 637-642.
77. Tassell MC, Kingston R, Gilroy D, Lehane M, Furey A 2010. Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease. Pharmacogn Rev 4: 32-41.
78. Tauchert M 2002. Efficacy and safety of Crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure. Am Heart J 143: 910-915.
79. Verma SK, Jain V, Verma D, Khamesra R 2007. Crataegus oxyacantha-A cardioprotective herb. J Herbal Med Toxicol 1: 65-71.
80. Vivar-Vera MA, Salazar-Montoya JA, Calva-Calva G, Ramos-Ramirez EG 2007. Extraction, thermal stability and kinetic behavior of pectinmethylesterase from hawthorn (Crataegus pubescens) fruit. Food Sci Technol 40: 278-284.
81. Wagner H, Grevel J 1982. Cardioactive drugs IV. Planta Med 6: 98-101.
82. Walker AF, Marakis G, Simpson E, Hope JL, Robinson PA, Hassanein M, Simpson HCR 2006. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs. Brit J Gen Prac 437-443.
83. Wang T, Zhang P, Zhao C, Zhang Y, Liu H, Hu L, Gao X, Zhang D 2011. Prevention effect in selenite-induced cataract in vivo and antioxidative effects in vitro of Crataegus pinnatifida leaves. Biol Trace Elem Res 142: 106-116.
84. Weikl A, Assmus KD, Neukum-Schmidt A, Schmitz J, Zapfe G, Noh HS, Siegrist J 1996. Crataegus special extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II). Fortschr Med 114: 291-296.
85. WHO, 2003. Monographs on medicinal plants newly independent states, p. 91-93.
86. ®1442 in congestive heart failure NYHA class II. Phytomedicine 8: 262-266.
87. Zhang PC, Xu XU 2001. Flavonoid ketohexosefuranosides from the leaves of Crataegus pinnatifida Bge. var. major N.E. Br. Phytochemistry 57: 1249-1253.
88. Zhang PC, Zhou YJ, Xu SX 2000. Two novel flavonoid glycosides from Crataegus pinnatifida Bge. var. major N.E. Br. J Asian Nat Prod Res 3: 77-82.
89. Zick SM, Gillespie B, Aaronson KD 2008. The effect of Crataegus oxycantha special extract WSS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure. Eur J Heart Fail 10: 587-593.
90. Zick SM, Gillespie B, Aaronson KD, Vautaw BM 2009. Hawthorn extract randomized blinded chronic heart failure (HERB CHF) trial. Eur J Heart Fail 11: 990-999.